Request for Covid-19 Impact Assessment of this Report
Production, means the output of Plasminogen Activator Inhibitor
Revenue, means the sales value of Plasminogen Activator Inhibitor
This report studies Plasminogen Activator Inhibitor in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Abbott Diagnostics, Inc. (USA)
Ortho-Clinical Diagnostics, Inc. (USA)
Singulex, Inc. (USA)
Alere, Inc. (USA)
Siemens Healthcare Diagnostics, Inc. (USA)
Beckman Coulter, Inc. (USA)
Roche Diagnostics Corp. (Switzerland)
Randox Laboratories Ltd. (UK)
Biomerieux SA (France)
Boditech Med Inc. (South Korea)
Labsystems Diagnostics OY (Finland)
BG Medicine, Inc. (USA)
LifeSign LLC (USA)
LSI Medience Corporation (Japan)
Response Biomedical Corp. (Canada)
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Plasminogen Activator Inhibitor in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Plasminogen Activator Inhibitor in each application, can be divided into
Application 1
Application 2
Application 3
Global Plasminogen Activator Inhibitor Market Research Report 2016
1 Plasminogen Activator Inhibitor Market Overview
1.1 Product Overview and Scope of Plasminogen Activator Inhibitor
1.2 Plasminogen Activator Inhibitor Segment by Type
1.2.1 Global Production Market Share of Plasminogen Activator Inhibitor by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Plasminogen Activator Inhibitor Segment by Application
1.3.1 Plasminogen Activator Inhibitor Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Plasminogen Activator Inhibitor Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Plasminogen Activator Inhibitor (2011-2021)
2 Global Plasminogen Activator Inhibitor Market Competition by Manufacturers
2.1 Global Plasminogen Activator Inhibitor Production and Share by Manufacturers (2015 and 2016)
2.2 Global Plasminogen Activator Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Plasminogen Activator Inhibitor Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Plasminogen Activator Inhibitor Manufacturing Base Distribution, Sales Area and Product Type
2.5 Plasminogen Activator Inhibitor Market Competitive Situation and Trends
2.5.1 Plasminogen Activator Inhibitor Market Concentration Rate
2.5.2 Plasminogen Activator Inhibitor Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Plasminogen Activator Inhibitor Production, Revenue (Value) by Region (2011-2016)
3.1 Global Plasminogen Activator Inhibitor Production and Market Share by Region (2011-2016)
3.2 Global Plasminogen Activator Inhibitor Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Plasminogen Activator Inhibitor Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Plasminogen Activator Inhibitor Consumption by Regions (2011-2016)
4.2 North America Plasminogen Activator Inhibitor Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Plasminogen Activator Inhibitor Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Plasminogen Activator Inhibitor Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Plasminogen Activator Inhibitor Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Plasminogen Activator Inhibitor Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Plasminogen Activator Inhibitor Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Plasminogen Activator Inhibitor Production, Revenue (Value), Price Trend by Type
5.1 Global Plasminogen Activator Inhibitor Production and Market Share by Type (2011-2016)
5.2 Global Plasminogen Activator Inhibitor Revenue and Market Share by Type (2011-2016)
5.3 Global Plasminogen Activator Inhibitor Price by Type (2011-2016)
5.4 Global Plasminogen Activator Inhibitor Production Growth by Type (2011-2016)
6 Global Plasminogen Activator Inhibitor Market Analysis by Application
6.1 Global Plasminogen Activator Inhibitor Consumption and Market Share by Application (2011-2016)
6.2 Global Plasminogen Activator Inhibitor Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Plasminogen Activator Inhibitor Manufacturers Profiles/Analysis
7.1 Abbott Diagnostics, Inc. (USA)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Abbott Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Ortho-Clinical Diagnostics, Inc. (USA)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Ortho-Clinical Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Singulex, Inc. (USA)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Singulex, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Alere, Inc. (USA)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Alere, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Siemens Healthcare Diagnostics, Inc. (USA)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Siemens Healthcare Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Beckman Coulter, Inc. (USA)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Beckman Coulter, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Roche Diagnostics Corp. (Switzerland)
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Roche Diagnostics Corp. (Switzerland) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Randox Laboratories Ltd. (UK)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Randox Laboratories Ltd. (UK) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Biomerieux SA (France)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Biomerieux SA (France) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Boditech Med Inc. (South Korea)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Plasminogen Activator Inhibitor Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Boditech Med Inc. (South Korea) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Labsystems Diagnostics OY (Finland)
7.12 BG Medicine, Inc. (USA)
7.13 LifeSign LLC (USA)
7.14 LSI Medience Corporation (Japan)
7.15 Response Biomedical Corp. (Canada)
8 Plasminogen Activator Inhibitor Manufacturing Cost Analysis
8.1 Plasminogen Activator Inhibitor Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Plasminogen Activator Inhibitor
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Plasminogen Activator Inhibitor Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Plasminogen Activator Inhibitor Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Plasminogen Activator Inhibitor Market Forecast (2016-2021)
12.1 Global Plasminogen Activator Inhibitor Production, Revenue Forecast (2016-2021)
12.2 Global Plasminogen Activator Inhibitor Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Plasminogen Activator Inhibitor Production Forecast by Type (2016-2021)
12.4 Global Plasminogen Activator Inhibitor Consumption Forecast by Application (2016-2021)
12.5 Plasminogen Activator Inhibitor Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Plasminogen Activator Inhibitor
Figure Global Production Market Share of Plasminogen Activator Inhibitor by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Plasminogen Activator Inhibitor Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Plasminogen Activator Inhibitor Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Plasminogen Activator Inhibitor Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Plasminogen Activator Inhibitor Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Plasminogen Activator Inhibitor Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Plasminogen Activator Inhibitor Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Plasminogen Activator Inhibitor Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Plasminogen Activator Inhibitor Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Plasminogen Activator Inhibitor Production of Key Manufacturers (2015 and 2016)
Table Global Plasminogen Activator Inhibitor Production Share by Manufacturers (2015 and 2016)
Figure 2015 Plasminogen Activator Inhibitor Production Share by Manufacturers
Figure 2016 Plasminogen Activator Inhibitor Production Share by Manufacturers
Table Global Plasminogen Activator Inhibitor Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Plasminogen Activator Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Plasminogen Activator Inhibitor Revenue Share by Manufacturers
Table 2016 Global Plasminogen Activator Inhibitor Revenue Share by Manufacturers
Table Global Market Plasminogen Activator Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Plasminogen Activator Inhibitor Average Price of Key Manufacturers in 2015
Table Manufacturers Plasminogen Activator Inhibitor Manufacturing Base Distribution and Sales Area
Table Manufacturers Plasminogen Activator Inhibitor Product Type
Figure Plasminogen Activator Inhibitor Market Share of Top 3 Manufacturers
Figure Plasminogen Activator Inhibitor Market Share of Top 5 Manufacturers
Table Global Plasminogen Activator Inhibitor Production by Regions (2011-2016)
Figure Global Plasminogen Activator Inhibitor Production and Market Share by Regions (2011-2016)
Figure Global Plasminogen Activator Inhibitor Production Market Share by Regions (2011-2016)
Figure 2015 Global Plasminogen Activator Inhibitor Production Market Share by Regions
Table Global Plasminogen Activator Inhibitor Revenue by Regions (2011-2016)
Table Global Plasminogen Activator Inhibitor Revenue Market Share by Regions (2011-2016)
Table 2015 Global Plasminogen Activator Inhibitor Revenue Market Share by Regions
Table Global Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Table China Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Table India Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Plasminogen Activator Inhibitor Consumption Market by Regions (2011-2016)
Table Global Plasminogen Activator Inhibitor Consumption Market Share by Regions (2011-2016)
Figure Global Plasminogen Activator Inhibitor Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Plasminogen Activator Inhibitor Consumption Market Share by Regions
Table North America Plasminogen Activator Inhibitor Production, Consumption, Import & Export (2011-2016)
Table Europe Plasminogen Activator Inhibitor Production, Consumption, Import & Export (2011-2016)
Table China Plasminogen Activator Inhibitor Production, Consumption, Import & Export (2011-2016)
Table Japan Plasminogen Activator Inhibitor Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Plasminogen Activator Inhibitor Production, Consumption, Import & Export (2011-2016)
Table India Plasminogen Activator Inhibitor Production, Consumption, Import & Export (2011-2016)
Table Global Plasminogen Activator Inhibitor Production by Type (2011-2016)
Table Global Plasminogen Activator Inhibitor Production Share by Type (2011-2016)
Figure Production Market Share of Plasminogen Activator Inhibitor by Type (2011-2016)
Figure 2015 Production Market Share of Plasminogen Activator Inhibitor by Type
Table Global Plasminogen Activator Inhibitor Revenue by Type (2011-2016)
Table Global Plasminogen Activator Inhibitor Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Plasminogen Activator Inhibitor by Type (2011-2016)
Figure 2015 Revenue Market Share of Plasminogen Activator Inhibitor by Type
Table Global Plasminogen Activator Inhibitor Price by Type (2011-2016)
Figure Global Plasminogen Activator Inhibitor Production Growth by Type (2011-2016)
Table Global Plasminogen Activator Inhibitor Consumption by Application (2011-2016)
Table Global Plasminogen Activator Inhibitor Consumption Market Share by Application (2011-2016)
Figure Global Plasminogen Activator Inhibitor Consumption Market Share by Application in 2015
Table Global Plasminogen Activator Inhibitor Consumption Growth Rate by Application (2011-2016)
Figure Global Plasminogen Activator Inhibitor Consumption Growth Rate by Application (2011-2016)
Table Abbott Diagnostics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Ortho-Clinical Diagnostics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ortho-Clinical Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Ortho-Clinical Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Singulex, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Singulex, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Singulex, Inc. (USA) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Alere, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alere, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alere, Inc. (USA) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Siemens Healthcare Diagnostics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Siemens Healthcare Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Siemens Healthcare Diagnostics, Inc. (USA) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Beckman Coulter, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Beckman Coulter, Inc. (USA) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Beckman Coulter, Inc. (USA) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Roche Diagnostics Corp. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Diagnostics Corp. (Switzerland) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Diagnostics Corp. (Switzerland) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Randox Laboratories Ltd. (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Randox Laboratories Ltd. (UK) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Randox Laboratories Ltd. (UK) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Biomerieux SA (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biomerieux SA (France) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biomerieux SA (France) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Boditech Med Inc. (South Korea) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boditech Med Inc. (South Korea) Plasminogen Activator Inhibitor Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boditech Med Inc. (South Korea) Plasminogen Activator Inhibitor Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasminogen Activator Inhibitor
Figure Manufacturing Process Analysis of Plasminogen Activator Inhibitor
Figure Plasminogen Activator Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Plasminogen Activator Inhibitor Major Manufacturers in 2015
Table Major Buyers of Plasminogen Activator Inhibitor
Table Distributors/Traders List
Figure Global Plasminogen Activator Inhibitor Production and Growth Rate Forecast (2016-2021)
Figure Global Plasminogen Activator Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table Global Plasminogen Activator Inhibitor Production Forecast by Regions (2016-2021)
Table Global Plasminogen Activator Inhibitor Consumption Forecast by Regions (2016-2021)
Table Global Plasminogen Activator Inhibitor Production Forecast by Type (2016-2021)
Table Global Plasminogen Activator Inhibitor Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...